CHE vs Peers Stock Comparison

Chemed Prices as of Oct 27, 2026 Peers: Industry group
CHE Chemed Corp
$508.35 -0.6% 1M +16.4% 1Y
Market cap
$7.16B
P/E
25.4x
Revenue (TTM)
$2.66B
Div. yield
–
Home Health and Senior Care Healthcare

Percentile Scorecard

CHE

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCHE
Valuation 45 #51 of 92
Growth 14 #75 of 87
Profitability 62 #33 of 86
Financial Health 48 #51 of 97
Shareholder Returns 47 #30 of 56
Overall 43
  • CHE ranked among 102 companies in Healthcare Providers

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCHESPY
1 month -0.6% -0.2%
3 months -1.6% +3.9%
6 months +20.7% +8.2%
Year to date +18.8% +12.9%
1 year +16.4% +12.3%
3 years -10.0% +87.4%
3 years, per year -3.4% +23.3%
5 years +13.7% +67.9%
5 years, per year +2.6% +10.9%
10 years +266.9% +261.1%
10 years, per year +13.9% +13.7%

Risk

MeasureCHESPY
Volatility, 1Y 29.8% 12.7%
Downside volatility, 1Y 33.2% 12.7%
Beta vs S&P 500, 1Y 0.00 1.00
Return / volatility, 1Y 0.55 0.97
Max drawdown, 5Y -43.4% -25.4%
From 52-week high -8.0% -1.2%
52-week high $552.43 $779.14
52-week low $368.59 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCHE
P/E now vs peer median 23.7xmedian 24.6x
P/S now vs peer median 2.5xmedian 1.6x
EV/EBITDA now vs peer median —median 14.6x
P/FCF now vs peer median 20.7xmedian 21.6x
P/B now vs peer median 7.7xmedian 3.2x
PEG now vs peer median 2.38median 0.66

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCHE
Revenue $2.66B
Operating income $370.86M
Net income $282.40M
EPS (diluted) $21.40
Cash & equivalents $48.43M
Shares (diluted) 13.20M
Enterprise value $7.16B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCHE
P/E 23.7x
P/FCF 20.7x
P/Operating cash flow 18.3x
P/S 2.5x
P/B 7.7x
P/Tangible book 8.5x
EV/EBITDA –
EV/EBIT –
EV/Revenue 2.5x
EV/FCF –
EV/Operating cash flow 18.3x
PEG (3Y EPS CAGR) 2.38

Growth

14 metrics
MetricCHE
Revenue growth (1Y) 5.2%
Revenue CAGR (3Y) 6.1%
Gross profit growth (1Y) –
Gross profit CAGR (3Y) –
Operating income growth (1Y) 5.5%
Operating income CAGR (3Y) 6.1%
Net income growth (1Y) 1.3%
Net income CAGR (3Y) 4.9%
EPS growth (1Y) 10.6%
EPS CAGR (3Y) 10.0%
Operating cash flow growth (1Y) -13.5%
Operating cash flow CAGR (3Y) 4.1%
Free cash flow growth (1Y) –
Free cash flow CAGR (3Y) –

Profitability

14 metrics
MetricCHE
Gross margin –
EBITDA margin –
Operating margin –
Pretax margin –
Net margin –
FCF margin –
Operating cash flow margin 13.6%
Return on equity –
Return on assets –
Return on invested capital –
Return on capital employed –
Asset turnover 1.6x
Cash conversion (OCF / net income) 1.3x
Stock comp / revenue 1.2%

Financial Health

11 metrics
MetricCHE
Debt / assets –
Debt / equity –
Net debt / EBITDA –
Debt / FCF –
Liabilities / assets 49.9%
Equity / assets 50.1%
Interest coverage –
Current ratio 1.1x
Quick ratio –
Cash ratio –
Altman Z-score –

Shareholder Returns

7 metrics
MetricCHE
Dividend yield 0.5%
Net buyback yield –
Shareholder yield 0.5%
Payout ratio (earnings) –
Payout ratio (FCF) –
Dividend growth (1Y) –
Dividend CAGR (3Y) –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCHE
Forward P/E 19.2xFY2026
EPS, next fiscal year $26.52FY2026
EPS growth, next FY +23.1%FY2026
EPS growth, the year after +8.0%
Revenue, next fiscal year $2.66BFY2026
Revenue growth, next FY +5.1%FY2026
Revenue growth, the year after +15.2%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCHE
Held by institutions 100.0%
Institutions holding 527
Change in shares held, QoQ +2.8%
Institutions buying 276
Institutions selling 186
Buyers to sellers 1.48

Add a Peer

Largest companies in the same industry

Related Comparisons

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.